Avoid the pitfalls of one-sided collaborations with this new report from Clinica.
Bio-Device Licensing is a new report that assesses the critical success factors in drug/device collaborations, allowing both device and pharmaceutical companies to get the best out of these partnerships.
Bio-Device Licensing: Strategies for success will answer the following questions:
- What do interdisciplinary collaborations really mean for device, biotech and pharmaceutical companies? - Where can synergies be found and what are the challenges? - What are the next disruptive technologies? - What are the emerging collaboration trends? - What kind of partners are leading corporations seeking? - How are valuable partnerships between large and small companies established?
